|
Annual Acquisition Of Cancer Medicines And The Like 20252026 Group 06. Abiraterone Acetate, Zoledronic Acid, Anagrylide Hydrochloride, Anastrozole, Azacitidine, Bevacizumab, Bicalutamide, Bleomycin Sulfate, Bortezomibe, Capecitabin, Carboplatin, Carboplatin, Cyclophosphamide, Cyclophosphamide, Cyclin, Cisplatin, Citarabine, Cladribin, Chlorabambucila, Dacarbazine, Dasatinibe, Doxorrubicin Doxorubicin Doxorbicine, Doxorrubicin Hydrochloride, Etoposide, Fluoruracyl, Fluoruracyl, Calcium Folic, Grove, Gencitabidan Hydrochloride, Hydrochloride, Gosserrelin Acetate, Hydroxyurea, Ifosphamide, Ifosfamide, Imatinibe Mesylate, Rynotecan Hydrochloride, Megestrol Acetate, Melfalana, Mesna, Mesna, Methotrexate, Methotrexate, Methotrexate, Probiotic, Nilotinib, Oxaliplastin, Oxaliplastin, Paclitaxel, Paclitaxel, Sodium Pamidronate, Pertuzumab, Rituximab, Rituximab, Swab, Tamoxifen Citrate, Trastuzumab, Vimblastin, Vincristine
|
